Week 2

Discovery and Development of an HIV Drug

Semester:

This week one of our very own, an Andrews alumnus of the Chemistry Department of 1993, Dr. Brain Johns came to present on the topic of discovery and development of an HIV drug. Dr. Johns is the director of HIV Medicinal & DMPK, GlaxoSmithKline at Research Triangle Park in North Carolina. Dr. Johns’ presentation was very interesting, targeting the area of chemistry I am most intrigued with, biochemistry. He presented well and was quite engaged, being well verse in his field and knowledgeable of his subject matter.

Development of an HIV Drug

Semester:

            This week at chemistry seminar we had the opportunity to learn about the drug discovery process from Dr. Brian Johns. It was very nice to know that Dr. Johns was a former Andrews University graduate. The seminar he presented was one of the best we have had all year. He presented the steps that a drug goes through from the idea to the final FDA approved product. This was very accessible even to those who have a limited chemistry background. He also went into the specifics of HIV and how it infects a T cell.

Discovery and Development of HIV drugs

Semester:

    The presentation was based on the discovery and development of a HIV drug by Dr. Brian Johns who graduated with a degree in chemistry from Andrews University. He then received his PhD in synthetic organic chemistry from Wayne State University and followed with his NIH postdoctoral fellowship at the University of Virginia. He is currently the director of the HIV Medicinal Chemistry. In his career he has help invent over 40 patents and patent applications.

Discovery and Development of an HIV Drug

Semester:

This week’s chemistry seminar was on the topic of The Discovery and Development of an HIV Drug. The seminar was presented by Dr. Brian Johns. Dr. Brian Johns, who is an alumnus of Andrews University, is the director of the HIV Medicinal and DMPK GlaxoSmithFKline, Research Triangle Pack in North Caroline. Through years of study and hard work he has developed a drug that has enormous potential for HIV patients across the world. Dr. Johns was engaging throughout his entire presentation.

Discovery and Development of an HIV Drug

Semester:

The pharmaceutical is a growing industry but takes painstakingly long for drugs to be granted approval by the FDA. This week, Dr. Brian Johns, former alumni of Andrews University, from GlaxoSmithKline company based in North Carolina came to talk about the synthesis and discovery of a HIV integrase inhibiting drug that was recently approved by the FDA and can be sold to the public. The drug that was made was called dolutegravir or for a more generic name, Tivicay.